379 related articles for article (PubMed ID: 22815774)
1. Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.
Xie C; Song LB; Wu JH; Li J; Yun JP; Lai JM; Xie DY; Lin BL; Yuan YF; Li M; Gao ZL
PLoS One; 2012; 7(7):e40607. PubMed ID: 22815774
[TBL] [Abstract][Full Text] [Related]
2. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a.
Lin C; Wu Z; Lin X; Yu C; Shi T; Zeng Y; Wang X; Li J; Song L
Clin Cancer Res; 2011 May; 17(10):3089-99. PubMed ID: 21447726
[TBL] [Abstract][Full Text] [Related]
4. [Up-regulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma].
Xie C; Li J; Xie DY; Lin BL; Li MF; Gao ZL
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(27):2167-73. PubMed ID: 24284254
[TBL] [Abstract][Full Text] [Related]
5. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP.
Yu G; Zhang T; Jing Y; Bao Q; Tang Q; Zhang Y
Life Sci; 2017 Apr; 175():47-51. PubMed ID: 28315691
[TBL] [Abstract][Full Text] [Related]
6. Investigation of microRNA expression changes in HepG2 cell line in presence of URG4/URGCP and in absence of URG4/URGCP suppressed by RNA interference.
Dodurga Y; Yonguc GN; Avci CB; Bagci G; Gunduz C; Satiroglu-Tufan NL
Mol Biol Rep; 2012 Dec; 39(12):11119-24. PubMed ID: 23053999
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
9. Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.
Xie BH; He X; Hua RX; Zhang B; Tan GS; Xiong SQ; Liu LS; Chen W; Yang JY; Wang XN; Li HP
Cancer Biomark; 2016; 16(3):405-13. PubMed ID: 27062697
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression.
Dodurga Y; Gundogdu G; Tekin V; Koc T; Satiroglu-Tufan NL; Bagci G; Kucukatay V
Mol Biol Rep; 2014 Jul; 41(7):4595-9. PubMed ID: 24652203
[TBL] [Abstract][Full Text] [Related]
11. Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.
Xie C; Xie DY; Lin BL; Zhang GL; Wang PP; Peng L; Gao ZL
Br J Cancer; 2013 Sep; 109(5):1198-205. PubMed ID: 23887606
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
Li F; Dong X; Lin P; Jiang J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
[TBL] [Abstract][Full Text] [Related]
13. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.
Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
[TBL] [Abstract][Full Text] [Related]
14. URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway.
Liu Y; Xi Y; Chen G; Wu X; He M
J Orthop Surg Res; 2020 Jun; 15(1):226. PubMed ID: 32552851
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-16 via URGCP pathway contributes to glioma growth.
Hong L; Qing O; Ji Z; Chengqu Z; Ying C; Hao C; Minhui X; Lunshan X
Sci Rep; 2017 Oct; 7(1):13470. PubMed ID: 29044221
[TBL] [Abstract][Full Text] [Related]
16. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
17. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
18. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a.
Lin H; Dai T; Xiong H; Zhao X; Chen X; Yu C; Li J; Wang X; Song L
PLoS One; 2010 Dec; 5(12):e15797. PubMed ID: 21203424
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
20. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]